Anagenics Ltd

ASX:AN1 (Australia)  
A$ 0.01 (0%) May 3
At Loss
P/B:
0.47
Market Cap:
A$ 4.15M ($ 2.74M)
Enterprise V:
A$ 3.67M ($ 2.43M)
Volume:
1.66M
Avg Vol (2M):
509.77K
Also Trade In:
Volume:
1.66M
At Loss
Avg Vol (2M):
509.77K

Business Description

Description
Anagenics Ltd has evolved into a growing beauty, health, and wellness business with a portfolio of functional skin, hair, and wellness brands. It develops and sells differentiated and clinically validated solutions for a range of conditions associated with aging. It includes validated consumer products to help people live longer, in good health, and with confidence. Its brands include Evolis and Uspa.

Financial Strength

Name Current Vs Industry Vs History
Cash-To-Debt 1.55
Equity-to-Asset 0.63
Debt-to-Equity 0.12
Debt-to-EBITDA -0.42
Piotroski F-Score 5/9
0
1
2
3
4
5
6
7
8
9
Altman Z-Score -5.2
Distress
Grey
Safe
Beneish M-Score -2.54
Manipulator
Not Manipulator
WACC vs ROIC
WACC
ROIC

Momentum Rank

Name Current Vs Industry Vs History
5-Day RSI 33.56
9-Day RSI 36.1
14-Day RSI 37.57
6-1 Month Momentum % -39.13
12-1 Month Momentum % -36.36

Liquidity Ratio

Name Current Vs Industry Vs History
Current Ratio 1.44
Quick Ratio 0.59
Cash Ratio 0.36
Days Inventory 181.86
Days Sales Outstanding 34.89
Days Payable 107.38

Dividend & Buy Back

Name Current Vs Industry Vs History
3-Year Average Share Buyback Ratio -39.1
Shareholder Yield % 5.8

Profitability Rank

Name Current Vs Industry Vs History
Gross Margin % 46.56
Operating Margin % -26.92
Net Margin % -30.99
FCF Margin % -22.12
ROE % -40.64
ROA % -28.81
ROIC % -38.17
ROC (Joel Greenblatt) % -120.34
ROCE % -31.1

Financials

ASX:AN1's 30-Y Financials
Income Statement Breakdown FY
No Enough Data
Balance Sheet Breakdown
No Enough Data
Cashflow Statement Breakdown
No Enough Data

Historical Operating Revenue by Business Segment

Historical Operating Revenue by Geographic Region

5-Step DuPont Analysis as of
No Enough Data

Guru Trades

See Details
To

Insider Trades

See Details
To

Peter Lynch Chart

Y-axis scale:
Interactive Chart
To

Performance

Dividend
Log
Bar
To

Annualized Return %  

Symbol
1 Week
1 Month
3 Months
6 Months
YTD
1 Year
3 Years
5 Years
10 Years

Total Annual Return %  

Symbol
2024
2023
2022
2021
2020
2019
2018
2017
2016
2015

Anagenics Ltd Executives

Details

Valuation Chart

Year:

Analyst Estimate

Key Statistics

Name Value
Revenue (TTM) (Mil A$) 10.197
EPS (TTM) (A$) -0.008
Beta 0.73
Volatility % 53.66
14-Day RSI 37.57
14-Day ATR (A$) 0.000803
20-Day SMA (A$) 0.01015
12-1 Month Momentum % -36.36
52-Week Range (A$) 0.009 - 0.028
Shares Outstanding (Mil) 461.32

Piotroski F-Score Details

Year:
Component Result
Piotroski F-Score 5
Positive ROA
Positive CFROA
Higher ROA yoy
CFROA > ROA
Lower Leverage yoy
Higher Current Ratio yoy
Less Shares Outstanding yoy
Higher Gross Margin yoy
Higher Asset Turnover yoy

Anagenics Ltd Filings

Filing Date Document Date Form
No Filing Data

Anagenics Ltd Stock Events

Financials Calendars
Event Date Price(A$)
No Event Data

Anagenics Ltd Frequently Asked Questions

What is Anagenics Ltd(ASX:AN1)'s stock price today?
The current price of ASX:AN1 is A$0.01. The 52 week high of ASX:AN1 is A$0.03 and 52 week low is A$0.01.
When is next earnings date of Anagenics Ltd(ASX:AN1)?
The next earnings date of Anagenics Ltd(ASX:AN1) is .
Does Anagenics Ltd(ASX:AN1) pay dividends? If so, how much?
Anagenics Ltd(ASX:AN1) does not pay dividend.

Press Release

Subject Date
No Press Release